The legal marijuana market has been evolving rapidly since 2012, when Colorado and Washington became the first U.S. states to legalize cannabis for recreational adult use. 22 additional U.S. states, two U.S. territories, and the District of Columbia have since joined them. On the world stage, recreational cannabis is now legal in Canada, Uruguay, and Malta. Several more countries, like Germany, Switzerland, and Poland, are in the process of considering more liberal marijuana policies, possibly opening the door to widespread legalization in these countries.
With the political movement to legalize marijuana gaining momentum worldwide, it might be a good time to start loading up on high-quality marijuana stocks. Aurora Cannabis(NASDAQ: ACB) and Tilray Brands(NASDAQ: TLRY) are two of the most prominent names in the legal cannabis space today. Both companies originate in Canada, but they have ambitions to become global leaders in the cannabis industry. Which stock is the better buy? Let's dig deeper to find out.
Image source: Getty Images.
The case for Aurora Cannabis
Aurora Cannabis is Canada's top medical marijuana producer by market share. It also has a large and growing footprint in 12 other areas, including high-value markets like Germany, Australia, and France. The company has also been investing heavily in research and development to create innovative and differentiated products that can help it build brand recognition and an economic moat. On the financial side of the ledger, Aurora's management thinks the company is on track to become cash flow positive in calendar year 2024.
However, Wall Street isn't convinced about the company's near-term financial goals. Despite Aurora's recent expansion into the profitable ornamental flowers segment, most analysts think the company remains a few years away from being cash flow positive consistently. The company also lacks a robust strategy to enter the high-value U.S. market upon the end of federal prohibition. Although this may not be a major concern in the short term, as the U.S. is unlikely to end federal prohibition anytime soon, it could limit Aurora's long-term growth potential.
The case for Tilray Brands
Tilray Brands is a leader in the legal marijuana market in Canada with an industry-best 13.4% market share, and in several other countries where medical marijuana is permitted, such as Germany, Poland, and Portugal. The company also has a strong presence in the craft alcohol and beer industry through its recent expansion efforts. This non-cannabis segment is expected to be a key pillar of growth for the company while the legal marijuana industry slowly matures.
Despite its diversification strategy, Tilray is still struggling to generate positive free cash flow. The company hopes to change this situation by the end of its current fiscal year, but some analysts are skeptical. For example, Morningstar's Kristoffer Inton believes that Tilray will not reach consistent profitability until late 2024 (calendar year) or early 2025. If that's true, Tilray would still be among the first within its Canadian peer group to reach this important financial milestone.
Which stock is the better buy?
Because of its diversification strategy into craft alcohol and beer, Tilray arguably screens as the better buy right now. Aurora's focus on the medical marijuana segment should prove to be a smart move over the long run, but Tilray seems closer to reaching sustainable profitability than its rival, Aurora. That being said, both of these cannabis companies face significant challenges. The legal cannabis market is growing fast, but several obstacles limit its appeal to investors at the moment.
Should you invest $1,000 in Aurora Cannabis right now?
Before you buy stock in Aurora Cannabis, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Aurora Cannabis wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of the S&P 500 since 2002*.
*Stock Advisor returns as of December 18, 2023
George Budwell has no position in any of the stocks mentioned. The Motley Fool recommends Tilray Brands. The Motley Fool has a disclosure policy.
